
Encompass Health (EHC) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.5B
Gross Profit
630.9M
43.35%
Operating Income
267.0M
18.35%
Net Income
196.5M
13.50%
EPS (Diluted)
$1.48
Balance Sheet Metrics
Total Assets
6.6B
Total Liabilities
3.7B
Shareholders Equity
2.9B
Debt to Equity
1.26
Cash Flow Metrics
Operating Cash Flow
289.3M
Free Cash Flow
125.5M
Revenue & Profitability Trend
Encompass Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 5.4B | 4.8B | 4.3B | 4.0B | 3.6B |
Cost of Goods Sold | 3.1B | 218.3M | 202.1M | 184.2M | 171.0M |
Gross Profit | 2.2B | 4.6B | 4.1B | 3.8B | 3.4B |
Gross Margin % | 41.6% | 95.5% | 95.4% | 95.4% | 95.2% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 266.5M | 2.9B | 2.6B | 2.4B | 2.1B |
Other Operating Expenses | 802.6M | 719.1M | 670.4M | 595.9M | 545.1M |
Total Operating Expenses | 1.1B | 3.6B | 3.3B | 3.0B | 2.7B |
Operating Income | 864.5M | 731.8M | 630.2M | 659.4M | 530.4M |
Operating Margin % | 16.1% | 15.2% | 14.5% | 16.4% | 14.9% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 137.4M | 143.5M | 175.7M | 164.3M | 183.7M |
Other Non-Operating Income | 22.5M | 18.9M | -3.7M | 9.9M | 6.2M |
Pre-tax Income | 749.6M | 607.2M | 450.8M | 505.0M | 352.9M |
Income Tax | 150.2M | 132.2M | 100.1M | 101.9M | 74.7M |
Effective Tax Rate % | 20.0% | 21.8% | 22.2% | 20.2% | 21.2% |
Net Income | 596.6M | 463.0M | 365.9M | 517.2M | 368.8M |
Net Margin % | 11.1% | 9.6% | 8.4% | 12.9% | 10.3% |
Key Metrics | |||||
EBITDA | 1.2B | 1.0B | 871.5M | 889.9M | 744.7M |
EPS (Basic) | $4.53 | $3.51 | $2.72 | $4.15 | $2.87 |
EPS (Diluted) | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 |
Basic Shares Outstanding | 99900000 | 99500000 | 99200000 | 99000000 | 98600000 |
Diluted Shares Outstanding | 99900000 | 99500000 | 99200000 | 99000000 | 98600000 |
Income Statement Trend
Encompass Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 85.4M | 69.1M | 21.8M | 49.4M | 224.0M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 598.8M | 611.6M | 536.8M | 515.8M | 572.8M |
Inventory | - | - | - | - | - |
Other Current Assets | 122.7M | 91.5M | 92.1M | 114.9M | 86.4M |
Total Current Assets | 886.9M | 841.8M | 717.2M | 921.4M | 948.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 203.7M | 208.5M | 212.5M | 193.7M | 245.7M |
Goodwill | 2.9B | 2.8B | 2.8B | 2.6B | 5.1B |
Intangible Assets | 298.8M | 278.2M | 282.3M | 158.4M | 431.3M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 219.2M | 191.6M | 222.1M | 1.8B | 295.0M |
Total Non-Current Assets | 5.6B | 5.3B | 4.9B | 5.9B | 5.5B |
Total Assets | 6.5B | 6.1B | 5.6B | 6.9B | 6.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 171.0M | 170.0M | 132.9M | 134.0M | 115.0M |
Short-term Debt | 164.9M | 48.9M | 50.8M | 61.3M | 83.1M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 238.6M | 187.4M | 181.1M | 309.7M | 218.3M |
Total Current Liabilities | 841.0M | 656.4M | 575.9M | 748.8M | 717.3M |
Non-Current Liabilities | |||||
Long-term Debt | 2.5B | 2.9B | 2.9B | 3.4B | 3.5B |
Deferred Tax Liabilities | 105.2M | 87.0M | 83.0M | 23.3M | 51.8M |
Other Non-Current Liabilities | 190.4M | 177.9M | 174.2M | 172.7M | 215.0M |
Total Non-Current Liabilities | 2.8B | 3.1B | 3.2B | 3.7B | 3.7B |
Total Liabilities | 3.7B | 3.8B | 3.8B | 4.5B | 4.4B |
Equity | |||||
Common Stock | 1.2M | 1.2M | 1.1M | 1.1M | 1.1M |
Retained Earnings | 796.7M | 406.5M | 115.7M | 141.8M | -242.3M |
Treasury Stock | 577.9M | 547.2M | 536.7M | 521.2M | 497.4M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.8B | 2.3B | 1.9B | 2.4B | 2.0B |
Key Metrics | |||||
Total Debt | 2.7B | 2.9B | 3.0B | 3.5B | 3.5B |
Working Capital | 45.9M | 185.4M | 141.3M | 172.6M | 231.3M |
Balance Sheet Composition
Encompass Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 599.4M | 475.0M | 350.7M | 403.1M | 278.2M |
Depreciation & Amortization | 299.6M | 273.9M | 243.6M | 219.6M | 203.0M |
Stock-Based Compensation | 48.3M | 50.6M | 29.2M | 29.1M | 25.6M |
Working Capital Changes | 58.8M | 5.0M | -7.2M | -37.7M | 15.3M |
Operating Cash Flow | 1.0B | 823.1M | 674.2M | 636.7M | 570.6M |
Investing Activities | |||||
Capital Expenditures | -642.5M | -583.1M | -584.1M | -545.7M | -392.8M |
Acquisitions | - | - | 0 | -118.6M | 0 |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -653.3M | -602.8M | -623.5M | -665.7M | -392.7M |
Financing Activities | |||||
Share Repurchases | -31.1M | - | 0 | 0 | -6.1M |
Dividends Paid | -62.8M | -60.4M | -99.0M | -112.2M | -111.8M |
Debt Issuance | 95.0M | 80.0M | 251.8M | 300.0M | 1.3B |
Debt Repayment | -337.0M | -163.3M | -750.0M | -359.1M | -1.1B |
Financing Cash Flow | -330.6M | -197.2M | -660.8M | -329.9M | -179.3M |
Free Cash Flow | 360.3M | 267.7M | 121.7M | 170.1M | 300.1M |
Net Change in Cash | 57.3M | 23.1M | -610.1M | -358.9M | -1.4M |
Cash Flow Trend
Encompass Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.81
Forward P/E
25.55
Price to Book
5.40
Price to Sales
2.17
PEG Ratio
0.96
Profitability Ratios
Profit Margin
9.22%
Operating Margin
17.77%
Return on Equity
24.72%
Return on Assets
9.18%
Financial Health
Current Ratio
1.06
Debt to Equity
86.97
Beta
0.74
Per Share Data
EPS (TTM)
$5.13
Book Value per Share
$22.60
Revenue per Share
$56.55
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ehc | 12.3B | 23.81 | 5.40 | 24.72% | 9.22% | 86.97 |
HCA Healthcare | 94.2B | 16.91 | -76.81 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.18 | 4.20 | 29.65% | 7.18% | 158.70 |
Universal Health | 11.6B | 9.62 | 1.65 | 18.79% | 7.66% | 70.09 |
DaVita | 9.8B | 13.45 | 6.68 | 57.94% | 6.35% | 825.19 |
Ensign Group | 9.6B | 30.10 | 4.72 | 17.54% | 7.00% | 100.93 |
Financial data is updated regularly. All figures are in the company's reporting currency.